Related Experiment Video
Updated: Aug 24, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex
Zhiyue Su1, Zelong Sun1, Zhao Wang1
1Soochow University Laboratory of Cancer Molecular Genetics, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China; Department of Genetics, School of Biology and Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China.
Abstract:
The molecular underpinnings of lung adenocarcinoma (LUAD) metastasis remain poorly defined. Here, using human LUAD cell lines, we find that transcriptional intermediary factor 1 γ (TIF1γ) binds to TATA box binding protein (TBP) in competition with TBP-associated factor 15 (TAF15) and impedes TAF15/TBP-mediated interleukin 6 (IL-6) transactivation. TIF1γ modifies TAF15 through multi-mono-ubiquitylation and drives nuclear export of TAF15. Functionally, TAF15 accelerates epithelial-mesenchymal transition (EMT) and metastasis of LUAD cells, acting in just the opposite way as TIF1γ. Low TIF1γ or high TAF15 expression levels are shown in metastatic LUAD specimens and correlate with poor survival of individuals with LUAD. Our findings suggest that the TAF15/TBP complex is required for IL-6 activation-induced EMT and invasion, which are inhibited by TIF1γ. This study highlights the crucial interaction between TIF1γ and the TAF15/TBP complex for regulating EMT and metastasis in LUAD.
Insights
Transcriptional intermediary factor 1 γ (TIF1γ) inhibits lung adenocarcinoma (LUAD) metastasis by blocking TAF15/TBP-mediated IL-6 transactivation. Low TIF1γ and high TAF15 expression correlate with poor LUAD patient survival.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The mechanisms driving lung adenocarcinoma (LUAD) metastasis are not fully understood.
- Identifying key regulators of LUAD cell invasion and epithelial-mesenchymal transition (EMT) is crucial for therapeutic development.
Purpose of the Study:
- To investigate the role of transcriptional intermediary factor 1 γ (TIF1γ) in regulating LUAD metastasis.
- To elucidate the molecular interactions between TIF1γ, TBP-associated factor 15 (TAF15), and TATA box binding protein (TBP) in LUAD.
Main Methods:
- Utilized human LUAD cell lines for molecular and functional studies.
- Investigated protein-protein interactions, including TIF1γ binding to TBP and competition with TAF15.
- Analyzed TAF15 modifications (multi-mono-ubiquitylation) and subcellular localization (nuclear export).
- Correlated TIF1γ and TAF15 expression levels with LUAD patient survival data.
Main Results:
- TIF1γ impedes TAF15/TBP-mediated interleukin-6 (IL-6) transactivation by binding to TBP and competing with TAF15.
- TIF1γ induces TAF15 multi-mono-ubiquitylation and nuclear export.
- TAF15 promotes EMT and metastasis, while TIF1γ inhibits these processes.
- Metastatic LUAD specimens show low TIF1γ and high TAF15 expression, correlating with poor survival.
Conclusions:
- The TAF15/TBP complex is essential for IL-6-induced EMT and invasion in LUAD.
- TIF1γ acts as an inhibitor of LUAD metastasis by disrupting the TAF15/TBP complex.
- The TIF1γ-TAF15 interaction is a critical regulator of EMT and metastasis in LUAD, offering potential therapeutic targets.
More Related Videos
07:39The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
Related Concept Videos
TGF - β Signaling Pathway
The Tumor Microenvironment
Regulation of Angiogenesis and Blood Supply
lncRNA - Long Non-coding RNAs
Intracellular Signaling Affects Focal Adhesions
Some...